Daniel MacArthur follows up on Steven Pinker's NYT story about having his genome sequenced with a blog post on the diversification of consumer genomics. All four of the current consumer genomics companies have staked their claim, with 23andMe focusing on fun, deCodeMe on academics, Navigenics on medical accuracy, and Knome on boutique offering.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.